159 related articles for article (PubMed ID: 3405782)
1. [Results of radioiodine treatment of patients with immunogenic and non-immunogenic hyperthyroidism using different focal doses].
Moser E; Pickardt CR; Mann K; Engelhardt D; Kirsch CM; Knesewitsch P; Tatsch K; Kreisig T; Kurz C; Saller B
Nuklearmedizin; 1988 Jun; 27(3):98-104. PubMed ID: 3405782
[TBL] [Abstract][Full Text] [Related]
2. [Results of radioiodine therapy in different forms of hyperthyroidism in relation to the planned dosage].
Moser E
Aktuelle Radiol; 1992 Jul; 2(4):179-87. PubMed ID: 1504115
[TBL] [Abstract][Full Text] [Related]
3. [Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease].
Guhlmann CA; Rendl J; Börner W
Nuklearmedizin; 1995 Feb; 34(1):20-3. PubMed ID: 7724360
[TBL] [Abstract][Full Text] [Related]
4. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
[TBL] [Abstract][Full Text] [Related]
5. Nonimmunogenic hyperthyroidism: cumulative hypothyroidism incidence after radioiodine and surgical treatment.
Kinser JA; Roesler H; Furrer T; Grütter D; Zimmermann H
J Nucl Med; 1989 Dec; 30(12):1960-5. PubMed ID: 2585096
[TBL] [Abstract][Full Text] [Related]
6. [Results of radioiodine therapy of manifest hyperthyroidism and autonomous struma with euthyroidism].
Berding G; Schicha H
Nuklearmedizin; 1990 Aug; 29(4):158-65. PubMed ID: 2216811
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
8. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
Sabri O; Zimny M; Schreckenberger M; Reinartz P; Nowak B; Ostwald E; Schäfer W; Block S; Setani K; Büll U
Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
10. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
Howarth D; Epstein M; Lan L; Tan P; Booker J
Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
[TBL] [Abstract][Full Text] [Related]
11. Results of radioiodine (131/125I) therapy of hyperthyroidism.
Glanzmann C; Horst W; Magdeburg W
Radiol Clin (Basel); 1975; 44(5):484-90. PubMed ID: 1208842
[TBL] [Abstract][Full Text] [Related]
12. [Experience with ambulatory radioiodine therapy of hyperthyroidism].
Róka R; Séra T; Valkusz Z; Julesz J; Csernay L; Pávics L
Orv Hetil; 1999 Jun; 140(23):1291-5. PubMed ID: 10412264
[TBL] [Abstract][Full Text] [Related]
13. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
[TBL] [Abstract][Full Text] [Related]
14. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
15. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
[TBL] [Abstract][Full Text] [Related]
17. [131I-therapy of Basedow's disease and nonimmunogenic hyperthyroidism].
Hoeschel M; Heinze HG
Nuklearmedizin; 1984 Jun; 23(3):143-9. PubMed ID: 6548309
[TBL] [Abstract][Full Text] [Related]
18. Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?
Kobe C; Weber I; Eschner W; Sudbrock F; Schmidt M; Dietlein M; Schicha H
Nuklearmedizin; 2008; 47(4):153-6. PubMed ID: 18690374
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine treatment of Plummer's disease.
Moser E
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S63-5. PubMed ID: 9867200
[TBL] [Abstract][Full Text] [Related]
20. What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?
Gotthardt M; Rubner C; Bauhofer A; Berce F; Oyen WJ; Goecke J; Pfestroff A; Schlieck A; Corstens FH; Béhé M; Behr TM
Nuklearmedizin; 2006; 45(5):206-12. PubMed ID: 17043731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
